These data demonstrate that LXRβ, but not LXRα, controls AQP1 expression in the pancreas, thus linking dietary resistance to weight gain treatments, and pancreatic insufficiency due to impaired pancreatic exocrine secretion mediated by AQP1 [85]. The gene discussed is NR1H2; the disease is exocrine pancreatic insufficiency.